资讯_贵商网

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women TVB-009P, Teva’s proposed biosimilar to Prolia, ...

贵商网

2024-10-09

资讯

实力加冕！Witsbb健敏思获平台双项大奖双11正式启航

近日，各平台一年一度的双11行业商家大会在陆续开展。大会期间，行业生态圈的多元参与者汇聚在一起，分享行业经验，聚焦增长策略。Witsbb健敏思作为澳企Forestpark旗下综合膳食营养补充品牌，在行业商家大会期间连获...

贵商网

2024-10-09

资讯

ORBCOMM joins Move to -15°C coalition to promote cold chain sustainability

ORBCOMM partners with industry stakeholders to accelerate climate action and reduce greenhouse gas emissions, energy consumption and supply chain costs ROCHELLE PARK, N.J., Oct. 08, 2...

贵商网

2024-10-09

资讯

Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces

Commercial 5G Standalone Enabling secure tailored end-to-end communications Dedicated slices to meet specific needs of the Armed Forces Extending strategic partnership with key customer OSLO,...

贵商网

2024-10-09

资讯

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on ...

贵商网

2024-10-09

资讯

Nasdaq Launches PureStream in Europe – A new tool for trajectory trading

STOCKHOLM, Oct. 08, 2024 (GLOBE NEWSWIRE) - Nasdaq (Nasdaq: NDAQ) today announced the planned launch of PureStream, a new volume-based trajectory trading solution giving clients access to EU shares ...

贵商网

2024-10-09

资讯